# Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer

> **NCT00905047** · PHASE3 · COMPLETED · sponsor: **Centre Oscar Lambret** · enrollment: 89 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** XELODA
- **DRUG:** TEGAFUR URACIL - FOLINIC ACID

## Key facts

- **NCT ID:** NCT00905047
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11-14
- **Primary completion:** 2010-06
- **Final completion:** 2011-09
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00905047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00905047, "Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00905047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*